Phibro Animal Health | PAHC - DEBITO





DEBITO Cambiamento Data
Align Technology USD 114.45M 6.82M 2025-12
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Aurora Cannabis CAD 23.86M 76.48M 2026-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Canopy Growth CAD 278.71M 19.38M 2026-03
Corcept Therapeutics USD 6.11M 251K 2025-12
Eli Lilly USD 42.5B 3.6M 2025-12
Henry Schein USD 3.75B 313M 2026-03
Idexx Laboratories USD 1.11B 129.39M 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Merck USD 49.34B 7.97B 2025-12
Nektar Therapeutics USD 0 0 2022-06
Pacira USD 367.66M 4.53M 2026-03
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.08B 38.27M 2025-12
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12
Zoetis USD 9.24B 1.96B 2025-12